Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for ICLR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Max Drawdown (5Y) Chart
Start Trial

Historical Max Drawdown (5Y) Data

View and export this data back to 1998. Start Trial.
Date Value
July 31, 2026 76.87%
June 30, 2026 76.87%
May 31, 2026 76.87%
April 30, 2026 76.87%
March 31, 2026 76.87%
February 28, 2026 76.87%
January 31, 2026 63.43%
December 31, 2025 63.43%
November 30, 2025 63.43%
October 31, 2025 63.43%
September 30, 2025 63.43%
August 31, 2025 63.43%
July 31, 2025 63.43%
June 30, 2025 63.43%
May 31, 2025 63.43%
April 30, 2025 60.49%
March 31, 2025 49.45%
February 28, 2025 47.24%
January 31, 2025 45.92%
December 31, 2024 45.92%
November 30, 2024 45.92%
October 31, 2024 43.85%
September 30, 2024 43.85%
August 31, 2024 43.85%
July 31, 2024 43.85%
Date Value
June 30, 2024 43.85%
May 31, 2024 43.85%
April 30, 2024 43.85%
March 31, 2024 43.85%
February 29, 2024 43.85%
January 31, 2024 43.85%
December 31, 2023 43.85%
November 30, 2023 43.85%
October 31, 2023 43.85%
September 30, 2023 43.85%
August 31, 2023 43.85%
July 31, 2023 43.85%
June 30, 2023 43.85%
May 31, 2023 43.85%
April 30, 2023 43.85%
March 31, 2023 43.85%
February 28, 2023 43.85%
January 31, 2023 43.85%
December 31, 2022 43.85%
November 30, 2022 43.85%
October 31, 2022 43.85%
September 30, 2022 40.83%
August 31, 2022 36.29%
July 31, 2022 36.29%
June 30, 2022 36.29%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
IQVIA Holdings, Inc. 51.52%
Medpace Holdings, Inc. 42.87%
Proteome Sciences Plc 92.81%
Champions Oncology, Inc. 78.53%
Avantor, Inc. 83.16%